← SynDRA
CGP-57380
SynDRA canonical compound SYN1957447 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | AURKB | LCK | MKNK1 | MKNK2 | SGK1 |
|---|
| Mechanism of action | MAP kinase inhibitor |
|---|
All known targets
- AURKB
- LCK
- MKNK1
- MKNK2
- SGK1
Mechanisms of action (all sources)
Cross-references
Synonyms
- CGP 57380
- MNK1 Inhibitor
- N3-(4-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine
- CGP57380
- CHEMBL1240885
- C11H9FN6
- 4-Amino-5-(4-fluoroanilino)-pyrazolo[3,4-d]pyrimidine
- SCHEMBL987991
- GTPL6010
- CHEMBL576817
- SCHEMBL16714452
- CHEBI:92749
- DTXSID50469941
- MolPort-006-725-822
- HMS3653G22
- HMS3269P13
- HMS3263L14
- HMS3229K20
- HMS3648M14
- Tox21_501256
- BDBM50130693
- 2314AH
- NSC741567
- MFCD03861062
- ZINC13816313
- s7421
- IN1236
- BDBM50298223
- AKOS024457265
- CCG-206868
- NSC-741567
- LP01256
- NCGC00162380-06
Look up CGP-57380 in the interactive SynDRA portal →